doi:

DOI: 10.3724/SP.J.1009.2013.00645

Chinese Journal of Natural Medicines (中国天然药物) 2013/11:6 PP.645-652

Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation


Abstract:
AIM: Silybin (SB), a major constituent of the milk thistle, has been used to treat several liver disorders. However, liver diseases were always accompanied by CYP450 dysfunction. This study was designed to explore the relationship between the hepatoprotective effect and CYP3A regulation of SB during thioacetamide (TAA)-induced rat liver injury. METHODS: Serum biochemical analysis and histopathological study were taken to evaluate the hepatoprotectinve effect of SB. α-SMA were detected by immunohistochemical analysis and cytokine release in rat liver was determined by ELISA assay. CYP3A and PXR expression were determined by RT-PCR and Western blot analysis, and CYP3A activity was based on the midazolam 4-hydroxylation reaction. Also, siRNA transfection was induced in HepG2 cells to evaluate the effect of PXR on cytotoxicity and CYP3A4 dysregulation caused by TAA. RESULTS: SB showed powerful hepatoprotective effects, and anti-inflammatory and anti-fibrosis effects, and reversed the loss of CYP3A and PXR in TAA-injured rat liver, and decreased PXR translocation into the cell nucleus. PXR silencing weakened the effect of SB on cyto-protection and CYP3A regulation. CONCLUSIONS: PXR was a very important factor of CYP3A regulation and might be the target of SB in TAA-induced liver disease. Also, because of the potential interactions of SB and co-administered medicines, it might be necessary to adjust the dosage in the clinical medication of liver disease.

Key words:Silybin,Thioacetamide,Liver injury,Inflammation,CYP3A,PXR

ReleaseDate:2014-07-21 17:04:19

Funds:National Natural Science Foundation of China (Nos. 81273586, 91029746, 81202590); the Natural Science Foundation of Jiangsu Province of China (No. SBK201240817); the Fundamental Research Funds for the Central Universities (No. JKQ2011040)



PDF